I agree that this site is using cookies. You can find further informations here.
X
Richie, Nicole
48  results:
Search for persons X
?
1

Advancing Inclusive Research (AIR) Site Alliance: Facilitat..:

Vidal, Gregory A. ; Chalela, Patricia ; Curry, Andrea N....
Contemporary Clinical Trials.  137 (2024)  - p. 107416 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Myths about diversity in clinical trials reduce return on i..:

Chaudhry, Mohammed Suhail ; Spahn, Jessica ; Patel, Shilpen...
Nature Medicine.  28 (2022)  8 - p. 1520-1522 , 2022
Link: https://doi.org/10.1038/..
 
?
3

Advancing Inclusive Research: Establishing Collaborative St..:

Garrick, Owen ; Mesa, Ruben ; Ferris, Andrea...
Ethnicity & Disease.  32 (2022)  1 - p. 61-68 , 2022
Link: https://www.jstor.org/st..
 
?
4

Contributors:

, In: Pragmatic Randomized Clinical Trials,
Alamri, Khaled ; Aldridge, Molly L. ; Alphs, Larry... - p. xiii-xvi , 2021
Link: https://doi.org/10.1016/..
 
?
5

Patient voice in clinical trial programs in industry:

, In: Pragmatic Randomized Clinical Trials,
Regnante, Jeanne M. ; Schrandt, Suzanne ; Richie, Nicole A.... - p. 47-70 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Operational strategies in US cancer centers of excellence t..:

Regnante, Jeanne M. ; Richie, Nicole ; Fashoyin-Aje, Lola...
Contemporary Clinical Trials Communications.  17 (2020)  - p. 100532 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Vemurafenib in Chinese patients with BRAFV600 mutation–posi..:

Si, Lu ; Zhang, Xiaoshi ; Xu, Zhen...
BMC Cancer.  18 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
8

A phase I open-label study to investigate the potential dru..:

Ruiz-Garcia, Ana ; Giri, Nagdeep ; LaBadie, Robert R....
The Journal of Clinical Pharmacology.  54 (2013)  5 - p. 555-562 , 2013
Link: https://doi.org/10.1002/..
 
?
9

Advancing Inclusive Research: Establishing Collaborative St..:

Garrick, Owen ; Mesa, Ruben ; Ferris, Andrea...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785867/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Disparities in Tumor Mutational Burden, Immunotherapy Use, ..:

Brawley, Otis W ; Luhn, Patricia ; Reese-White, Deonna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577674/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Modernizing Clinical Trial Eligibility Criteria: Recommenda..:

Spira, Alexander I ; Stewart, Mark D ; Jones, Suzanne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102342/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Operational strategies in US cancer centers of excellence t..:

Regnante, Jeanne M ; Richie, Nicole ; Fashoyin-Aje, Lola...
qt9mt7c04v.  , 2020
Link: https://escholarship.org..
 
?
13

Operational strategies in US cancer centers of excellence t..:

Regnante, Jeanne M ; Richie, Nicole ; Fashoyin-Aje, Lola...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005557/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Disparities in Tumor Mutational Burden, Immunotherapy Use, ..:

Otis W. Brawley ; Patricia Luhn ; Deonna Reese-White...
https://ascopubs.org/doi/10.1200/GO.21.00309.  , 2021
Link: https://doi.org/10.1200/..
 
?
15

Operational strategies in US cancer centers of excellence t..:

Jeanne M. Regnante ; Nicole Richie ; Lola Fashoyin-Aje...
http://www.sciencedirect.com/science/article/pii/S2451865420300168.  , 2020
Link: https://doi.org/10.1016/..
 
1-15